named programs · 4 · from sources
What they call their work
AVBCC Annual Conference
Flagship event convening leaders in oncology to discuss value-based care, featuring expert panels on topics such as outcomes-based contracting, AI in pharmacy, biomarker testing, and cell therapy reimbursement
Enhancing Oncology Model (EOM) Learning Forum
Program providing insights and best practices for community and hospital-based oncology practices participating in the CMS Enhancing Oncology Model, with focus on health equity, ePROs, and care navigation
Learning Ecosystem for Community Oncology
Collaborative network supporting community oncology practices in delivering expert-level, pathway-driven care through shared clinical pathways and trial matching, using multiple myeloma as a model
Value-Based Care Thought Leadership Series
Ongoing initiative hosting discussions on policy, payment reform, and innovation in cancer care delivery, including topics like Most Favored Nation pricing, PBM reform, and employer-aligned cancer solutions
activities · 4 groups
What they do
-
Scientific Conference & Symposium Management 2 activities
- Host Global Cancer Research & Innovation Symposium (GCRIS)Organizes an invitation-only, annual symposium that brings together leaders in cancer research and drug development to advance innovation through cross-sector collaboration. The event spans a day-and-a-half and focuses on fostering productive engagement among key stakeholders in oncology research.
- Host annual AVBCC Summit & Educational ProgramOrganizes and hosts an annual in-person and virtual summit for oncology stakeholders, featuring over 100 educational sessions on clinical, cost, access, and value-based care issues in cancer treatment. The event convenes more than 1,000 experts, including providers, payers, and researchers, and includes archived content available to attendees for one year.
-
-
Healthcare Professional Recognition Programs 1 activity
- Administer 40 Under 40 in Cancer AwardsRecognizes individuals under age 40 annually for outstanding contributions in the field of cancer through a formal nomination and selection process, with awardees honored at a private celebration. The program highlights emerging leaders across the cancer care ecosystem.
-
-
Healthcare Delivery Networks and Coalitions 1 activity
- Facilitate stakeholder collaboration on value-based cancer care modelsConvenes expert panels and discussions among oncology stakeholders to develop best practices in value-based cancer care, including hospital-physician alignment, outcomes-based contracting, pharmacy pricing models, and dedicated cancer diagnostic clinics. These forums aim to improve patient access, affordability, and quality of care across the cancer care ecosystem.
-
-
Cancer Research Funding 1 activity
- Fund early-career cancer research through grant supportSupports cancer research by funding organizations such as Conquer Cancer (ASCO Foundation) and Swim Across America, which award grants to young investigators pursuing breakthrough science in oncology. These initiatives aim to advance innovative cancer therapies and support the next generation of researchers.
-
financials · form 990 · fy2025
revenue
Total revenue$4.51M
Contributions & grants$00%
Program service revenue$4.51M100%
Investment income$00%
Other revenue$0
expenses
Total expenses$4.21M
Program expenses85%
Admin / overhead15%
Fundraising0%
Salaries & benefits$0
Grants paid out$0
Largest expense lineFacilities
balance sheet
Total assets$1.09M
Cash$547K
Investments$0
Liabilities$442K
Net assets$647K
Liquid reserves1.6 mo
5 years on record · 2020–2025 · YoY revenue +58.7%
leadership · form 990 part vii · fy2025
Who runs it
paid leadership · 3
| Name | Title | Hours/wk | Compensation |
|---|---|---|---|
| BURT ZWEIGENHAFT | TRUSTEE | 30 | $1.30M |
| RICHARD EISMAN | TRUSTEE | 1 | $65K |
| JOSEPH GROGAN | TRUSTEE | 1 | $13K |
board members · 1
- NICHOLAS SARLIS — TRUSTEE
relationships · 26
Who they work with
- ACS Partner — Collaborates with ACS on initiatives including patient advocacy and biomarker testing access.
- ASCO Partner — Features ASCO leadership in panels addressing risk-sharing models and quality innovation in cancer care delivery.
- ASCO Partner — Hosts the 40 Under 40 in Cancer awards alongside the ASCO Annual Meeting.
- ASCO Foundation Partner — Partners with the ASCO Foundation to support cancer research through the Young Investigator Award.
- American Cancer Society Partner — Partners on state-level biomarker testing access campaigns.
- Baptist Health South Florida Partner — Collaborates on addressing generic drug reimbursement challenges and provider sustainability.
- BehaviorLive Partner — Partners with BehaviorLive to host and distribute archived educational content from the AVBCC Summit.
- Boehringer Ingelheim Partner — Engages industry stakeholders like Boehringer Ingelheim in discussions on oncology care.
- CancerCare Partner — Collaborates on redefining patient-centered cancer care models.
- City of Hope Partner — Includes City of Hope leadership in discussions on generic drug reimbursement and supply chain stability.
- Conquer Cancer Partner — Supports Conquer Cancer's Young Investigator Award program.
- Ernst & Young LLP (EY) Partner — Engages EY experts in analyzing cancer care ecosystem transitions and forecasting future trends.
- Florida Cancer Specialists & Research Institute Partner — Engages physicians from Florida Cancer Specialists in panels on protected class status and second opinion practices.
- IQVIA Partner — Collaborates with IQVIA through faculty participation in AVBCC programming, including presentations on oncology market intelligence.
- IQVIA Institute for Human Data Science Partner — Works with IQVIA experts to analyze trends in cancer care using real-world data and industry insights.
- Illumina Partner — Involves Illumina leadership in discussions on clinical trial biomarker testing and reimbursement barriers.
- McKesson Partner — Engages McKesson executives as faculty members in panel discussions on market access, PBM reform, and value-based care models.
- Memorial Sloan Kettering Cancer Center Partner — Includes MSK representatives in discussions on employer-aligned cancer care solutions through its MSK Direct program.
- New York Athletic Club Partner — Host venue for the 2026 AVBCC Summit.
- Palmer House Partner — Venue for the annual 40 Under 40 in Cancer private celebration.
- Swim Across America Partner — Founding supporter of Swim Across America, which funds young investigators in cancer research.
- Tempus AI Partner — Collaborates with Tempus AI through faculty contributions on topics including second opinions, biomarker testing, and AI decision support.
- Tempus Labs Partner — Collaborates on AI applications in oncology and pharmacy benefit operations.
- Texas Oncology Partner — Includes Texas Oncology leadership in conversations on AI integration and strategic policy initiatives in oncology.
- Tigerlily Foundation Partner — Engages in patient-centered care discussions and advocacy efforts.
- organizations from across the oncology ecosystem Partner — Partner organizations sponsor the 40 Under 40 in Cancer awards.
strategies · 4
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Multi-Stakeholder Convening for Systemic Changemethodology: multistakeholder_collaborationBy bringing together payers, providers, regulators, industry leaders, and other key stakeholders in oncology, the organization drives systemic improvements in cancer care because cross-sector collaboration enables shared problem-solving, trust-building, and co-development of scalable solutions that no single entity could achieve alone.
- Outcomes-Based Contracting to Align Incentivesmethodology: outcome_based_contractingBy advocating for contracts tied to measurable health outcomes rather than service volume, the organization improves affordability and quality in cancer care because financial incentives are realigned around patient benefit, encouraging innovation and efficiency across providers and pharmaceutical developers.
- Patient-Led Care Reformmethodology: patient_led_care_reformBy placing patients at the center of decision-making in clinical, organizational, and policy settings, the organization produces more responsive and equitable cancer care systems because patient agency leads to higher relevance, dignity, and alignment with lived experience.
- Value-Based Assessment of Oncology Innovationsmethodology: value_based_assessmentBy applying a value-based framework to evaluate new therapies and practices, the organization ensures that only those with meaningful clinical impact and system-level benefit are adopted, because assessing beyond cost or novelty prevents diffusion of low-value care and strengthens resource allocation.